Quarum v. Mitchell International, Inc.

CourtSuperior Court of Delaware
DecidedJanuary 21, 2020
DocketN19C-03-087 AML CCLD
StatusPublished

This text of Quarum v. Mitchell International, Inc. (Quarum v. Mitchell International, Inc.) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Quarum v. Mitchell International, Inc., (Del. Ct. App. 2020).

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

MERRIT QUARUM, ) )

Plaintiff, )

)

V. ) C.A. No.: N19C-03-087 AML CCLD

MITCHELL INTERNATIONAL, ) INC., ) )

Defendant. )

Submitted: October 16, 2019 Decided: January 21, 2020

Upon Defendant’s Motion to Dismiss Count I of Plaintiff's Second Amended Complaint: Granted in Part, Denied in Part

MEMORANDUM OPINION

David P. Primack, Esquire, David W. Giattino, Esquire, of McELROY, DEUTSCH, MULVANEY & CARPENTER, LLP, Wilmington, Delaware, and Noah Jarrett, Esquire, of SCHWABE, WILLIAMSON & WYATT PC, Portland, Oregon, Attorneys for Plaintiff.

John P. DiTomo, Esquire, Alexandra Cumings, Esquire, of MORRIS, NICHOLS, ARSHT & TUNNELL LLP, Wilmington, Delaware, and Michael A. Duffy, Esquire, Michael C. McCutcheon, Esquire, of BAKER & McKENZIE LLP, Chicago, Illinois, Attorneys for Defendant.

LeGrow, J. In October 2016, buyer purchased sellers’ shares of QMedtrix Systems, Inc., and the parties executed a stock purchase agreement governing the sale. To complete the transaction, the parties also entered into an earnout agreement and an employment agreement calling for one of the sellers’ continued employment with the company. Two years later, sellers’ representative initiated this action against buyer alleging non-compliance with the earnout agreement along with various employment-related claims. Buyer answered and asserted several counterclaims against sellers for breach of contract, breach of trade secret acts, and conversion.

Buyer also moved to dismiss Count I of sellers’ complaint for failure to state a claim. That count alleges various breaches of the earnout agreement, specifically the section requiring buyer to undertake certain efforts intended to improve sales of QMedtrix’s products. The primary questions before the Court are (1) whether sellers adequately pleaded that buyer’s failure actively to promote the product breached a clause in the earnout agreement that prohibited buyer from taking actions that materially would reduce the earnout; and (2) whether sellers elected a remedy by sending notice that buyer’s failure to use commercially reasonable efforts extended the term of the contract. For the following reasons, I dismiss the majority of sellers’ claim relating to the material reduction clause. As to the remaining allegations in

Count I, I conclude sellers have not elected a remedy that precludes their damages claim here, and the balance of Count I therefore survives under the minimal pleading standard applicable to a motion to dismiss. FACTS AND PROCEDURAL BACKGROUND

The following facts are drawn from the complaint. On October 31, 2016 (the “Closing Date”), Dr. Merrit Quarum, along with Ann Bunnenberg, Steve Stratos, Ira M. Weintraud, and Linda C. Hall (collectively, the “Sellers”),! entered into a Stock Purchase Agreement (“SPA”) with Mitchell International, Inc. (“Mitchell”). Pursuant to the SPA, Mitchell acquired all Sellers’ shares of QMedtrix Systems, Inc. (“QMedtrix”). QMedtrix developed streamlined review and approval processes for physicians’ reimbursement claims with insurance companies related to workers compensation and automobile insurance claims (the “Solutions”).” The Earnout Agreement

As part of the transaction, Sellers and Mitchell also entered into an Earnout Agreement. The Earnout Agreement allowed Sellers to earn additional compensation based on sales of the Solutions to Mitchell’s customers during the first

two years after the Closing Date. Sellers believed the earnout amount would be

' “Under the terms of the SPA, Dr. Quarum was appointed as the Sellers’ Representative and empowered with the right to act as agent and attorney-in-fact for the Sellers with full power and authority to take all action necessary or appropriate in any claims that might arise between Mitchell and Sellers relating to the SPA and/or the Earnout Agreement.” PI.’s Second Am. Verified Compl. (hereinafter “Second Am. Compl.”) 5.

2 “

2 significant based on the Solutions’ past success and Mitchell’s obligations to promote the Solutions and utilize Dr. Quarum’s knowledge base.

Under the Earnout Agreement, Mitchell was obligated to provide Sellers a net margin certificate setting the net margin amount due each month, which was to be calculated based on the Solutions’ revenue. Additionally, Mitchell was obligated to pay, within 90 days following the last day of “Year 2,” the final earnout amount due based upon the Solutions and FairPay* revenue.

In order to make sure Mitchell marketed the Solutions to its customers, Section 6 of the Earnout Agreement contained specific covenants and obligations to which Mitchell agreed. Section 6 states relevantly:

(a) The Sellers acknowledge and agree that [Mitchell], as the ultimate

owner of [QMedtrix] from Closing, has the power to direct the

management, strategy and decisions of [QMeditrix]. Notwithstanding

the foregoing, [Mitchell] agrees it will, and it will cause [QMedtrix] to

and its affiliates to, act in good faith and in a commercially reasonable

manner to avoid taking actions that would reasonably be expected to

materially reduce the Contingent Payment Amounts or otherwise materially impede or delay the calculation of Revenue and Net Margin

in accordance with Appendix B[.]°

(b) [Mitchell] will act in good faith and use commercially reasonable

efforts to present and promote the Solutions to customers that could reasonably be expected to utilize the Solutions.®

3 Id. (defining “Year 2”).

4 Id. (defining “FairPay Solution” as “Buyer’s specialty bill review solution marketed and sold under the FairPay brand”).

> Td. § 6(a).

6 Id. § 6(b). (c) [Mitchell] will[,] . . . Gi) within six (6) months after the Closing

Date, (A) upgrade the existing bridge between [Mitchell’s]

SmartAdvisor system and build a new bridge to the DecisionPoint

system, that will allow [QMedtrix] to provide the Solutions to

[Mitchell’s] customers that have agreed to use the Solutions and to

calculate the Revenue and Net Margin generated from such customers

in accordance with Appendix B[.]’ The Employment Agreement

In connection with the SPA and the Earnout Agreement, Dr. Quarum, in his individual capacity, also agreed to become a Mitchell employee. Dr. Quarum and Mitchell agreed to employment terms and conditions in an Executive Employment Agreement, which stated Dr. Quarum could not be terminated before October 31, 2018 other than “for cause,” as the Employment Agreement defined that term.® Post-Closing Date

Dr. Quarum alleges Mitchell failed to act in good faith and use commercially reasonable efforts after the Closing Date “to present and promote the Solutions to its customers, and Mitchell [] wholly failed to perform the specific covenants required under the SPA.”? Dr. Quarum contends Mitchell took steps to sideline him by not

allowing him to participate in marketing the Solutions, and Mitchell “depressed the

amount of the Earnout by sidelining Dr. Quarum and diverting resources, including

” Td. § 6(c)(ii).

8 See Employment Agreement § III(A) (“[QMedtrix] will not terminate Executive’s employment other than For Cause . . . before the two (2) year anniversary of the Closing.”); id. § IV(A) (defining “For Cause”).

? Second Am. Compl. 20. customers, from the Solutions.”!° Additionally, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Doe v. Cahill
884 A.2d 451 (Supreme Court of Delaware, 2005)
Alliance Data Systems Corp. v. Blackstone Capital Partners v L.P.
963 A.2d 746 (Court of Chancery of Delaware, 2009)
Savor, Inc. v. FMR Corp.
812 A.2d 894 (Supreme Court of Delaware, 2002)
Estate of Osborn Ex Rel. Osborn v. Kemp
991 A.2d 1153 (Supreme Court of Delaware, 2010)
Rhone-Poulenc Basic Chemicals Co. v. American Motorists Insurance Co.
616 A.2d 1192 (Supreme Court of Delaware, 1992)
Spence v. Funk
396 A.2d 967 (Supreme Court of Delaware, 1978)
Stoltz Realty Co. v. Raphael
458 A.2d 21 (Supreme Court of Delaware, 1983)
VLIW TECHNOLOGY, LLC v. Hewlett-Packard Co.
840 A.2d 606 (Supreme Court of Delaware, 2003)
Ramunno v. Cawley
705 A.2d 1029 (Supreme Court of Delaware, 1998)
Pfeffer v. Redstone
965 A.2d 676 (Supreme Court of Delaware, 2009)
Fish Engineering Corporation v. Hutchinson
162 A.2d 722 (Supreme Court of Delaware, 1960)
Holmes v. D'Elia
129 A.3d 881 (Supreme Court of Delaware, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Quarum v. Mitchell International, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/quarum-v-mitchell-international-inc-delsuperct-2020.